| 英文名称 |
中文名称 |
CAS |
|
4-Hydroxy Omeprazole Sulfide
|
4-羟基奥美拉唑硫醚-2-基)甲基]磺酰基]-1氢-苯并咪唑 (奥美拉唑 砜) |
103876-98-8 |
|
5-METHOXY-2-[((4-METHOXY-3,5-DIMETHYL-1-OXIDO-2-PYRIDINYL)METHYL)SULFINYL]-BENZIMIDAZOLE
|
4-甲氧基-2-[[（RS）-（5-甲氧基-1H-苯骈咪唑-2-基）亚磺酰基]甲基]-3，5-二甲基吡啶1-氧化物 |
176219-04-8 |
|
5-METHOXY-2-[(3,5-DIMETHYL-2-PYRIDINYL)-METHYLSULFINYL]-BENZIMIDAZOLE
|
2-[（RS）-[（3，5-二甲基-2-吡啶基）甲基] 亚磺酰基]-5-甲氧基-1H-苯骈咪唑 |
110374-16-8 |
|
Pyridine, 4-chloro-2-(chloromethyl)-3,5-dimethyl-, hydrochloride
|
2-氯甲基 -3.5-二甲基-4-氯-吡啶盐酸盐 |
143016-68-6 |
|
(+)-(S)-(o-chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridine-5(4H)-acetic acid, hydrochloride
|
(S)-(o-氯苯基)-6,7-二羟噻吩[3,2-C]吡啶-5(4H)-乙酸盐酸盐 |
144750-42-5 |
|
(3R,5S,E)-7-(4-(4-fluorophenyl)-2-((2-hydroxy-N,2-dimethylpropyl)sulfonamido)-6-isopropylpyrimidin-5-yl)-3,5-dihydroxyhept-6-enoic acid sodium salt
|
瑞舒伐他汀钙EP杂质A（钠盐） |
1714147-47-3 |
|
Mirabegron impurity D
|
米拉贝隆杂质D |
|
|
Pentanamide,5-chloro-
|
5-氯戊酰胺 |
2455-05-2 |
|
4-Desmethyl-2-methyl Celecoxib;4-[5-(2-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzene-1-sulfonamide
|
塞来昔布异构体杂质 |
170569-99-0 |
|
METHYL 5-FORMYL-2,4-DIMETHYL-1H-PYRROLE-3-CARBOXYLATE
|
5-醛基-2, 4-二甲基-1H-吡咯-3-甲酸甲酯 |
58298-68-3 |
|
(1R)-3-(dimethylamino)-1-thiophen-2-ylpropan-1-ol
|
R-（+）-3-(二甲基氨基)-1-(2-噻吩基)-1-丙醇 |
132335-49-0 |
|
2-(4-nitrophenyl)ethyl methyl ether
|
2-(4-硝基苯基)乙基甲醚 |
69628-98-4 |
|
3-(Dimethylamino)-1-(3-thienyl)-1-propanone Hydrochloride
|
3-(二甲基氨基)-1-(3-噻吩基)-1-丙酮盐酸盐 |
14994-02-6 |
|
4-(2-methoxyethyl)aniline
|
4-(2-甲氧基乙基)苯胺 |
84803-56-5 |
|
4-[(1S)-3-(Methylamino)-1-(2-thienyl)propoxy]-1-naphthaleno
|
4-[(1S)-3-(甲基氨基)-1-(2-噻吩基)丙基]-1-萘酚 |
662149-13-5 |
|
Mixture of N-(4-Methoxy-3,5-dimethyl-2-pyridinyl)methyl Omeprazole and N'-(4-Methoxy-3,5-dimethyl-2-pyridinyl)methyl Omeprazole
|
N-(4-甲氧基-3,5-二甲基-2-吡啶)甲基 奥美拉唑 和 N’-(4-甲氧基-3,5-二甲基-2-吡啶)甲基 奥美拉唑 |
1346599-85-6 |
|
N-Methyl-3-(naphthalen-1-yloxy)-3-(thiophen-3-yl)propan-1-amine Oxalate
|
盐酸度洛西汀EP杂质F |
116817-28-8 |
|
N-Methyl-3-(naphthalen-1-yloxy)-3-(thiophen-3-yl)propan-2-amine
|
盐酸度洛西汀EP杂质F |
1104890-90-5 |
|
N-Methyl-3-(naphthalen-1-yloxy)-3-(thiophen-3-yl)propan-3-amine HCl
|
盐酸度洛西汀EP杂质F |
116817-27-7 |
|
rac-α-[2-(Dimethylamino)ethyl]-3-thiophenemethanol
|
N,N-二甲基-3-羟基-3-(2-噻吩基)丙胺 |
116817-84-6 |
|
R-DULOXETINE Oxalate
|
R-度洛西汀草酸盐 |
116539-60-7 |
|
5-(4-Bromophenyl)-4,6-dichloropyrimidine
|
5-(4-溴苯基)-4;马西替坦中间体2(5-(4-溴苯基)-4,6-二氯嘧 |
146533-41-7 |
|
Sitagliptin Fumarate Adduct(Sitagliptin Impurity FP-A)
|
西他列汀富马酸加成物 |
2088771-60-0 |
|
3,5-DIMETHYL 2-CHLORMETHYL PYRIDINE.HCL
|
2-氯甲基 -3.5-二甲基-吡啶盐酸盐 |
73590-93-9 |
|
(E)-5-(2, 5-dimethyl-4-(prop-1-enyl)phenoxy)-2, 2-dimethylpentanoic acid
|
吉非罗齐USP杂质A |
500904-61-0 |
|
(S)-2-(((2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)Methyl)aMino)-3- Methylbutanoic acid
|
N-[[2'(-(1H-四唑-5-基)[1,1'(-联苯]-4-基]甲基]-L-缬氨酸 |
676129-92-3 |
|
1-chloro-3-(propan-2-ylamino)propan-2-ol,hydrochloride
|
1-氯-3-异丙基氨基-2-丙醇盐酸盐 |
39552-14-2 |
|
1-Chloro-3-isopropylamino-2-propanol
|
1-氯-3-异丙基氨基-2-丙醇， |
50666-68-7 |
|
3-Morpholinone, 4-(2-aMinophenyl)-
|
3-吗啉酮,4-(2-氨基苯基) |
1082588-73-5 |
|
4-Butoxybutyl alcohol
|
4-丁氧基丁醇 |
4161-24-4 |
|
Atorvastatin EP IMpurity A
|
阿托伐他汀EP杂质A |
433289-83-9 |
|
Atorvastatin EP IMpurity C
|
阿托伐他汀钙杂质C |
693793-53-2 |
|
Defluoro Atorvastatin Acetonide tert-Butyl Ester
|
ATO-10脱氟杂质 |
1105067-91-1 |
|
Difluoro Atorvastatin Acetonide tert-Butyl Ester
|
ATO-10双氟杂质 |
693793-87-2 |
|
methyl (-)-(R)-(o-chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridine-5(4H)-acetate, hydrogen sulfate
|
氯吡格雷杂质C |
120202-71-3 |
|
Methyl(+/-)-(o-chlorophenyl)-4,5-dihydrothieno[2,3-c]pyridine-6(7H)-acetate, hydrochloride
|
(甲基(+/-)-(O-氯苯基)-4,5-二氢噻吩[2,3-C]吡啶-6(7H)-乙酸酯盐酸盐 |
144750-52-7 |
|
Metoprolol EP IMpurity M
|
美托洛尔EP杂质M |
343785-33-1 |
|
N-[4-(4-Fluorophenyl)-6-(1-methylethyl)-5-[(1E)-2-[(2S,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethenyl]-2-pyrimidinyl]-N-methylmethanesulfonamide
|
瑞舒伐他汀EP杂质D |
503610-43-3 |
|
Rosuvastatin Calcium Impurity C (EP)
|
瑞舒伐他汀EP杂质C |
1422619-13-3 |
|
Rosuvastatin EP impurity B
|
瑞舒伐他汀钙EP杂质B（钠盐） |
|
|
(S)-3-[1-(methylamino)ethyl]-phenyl N-ethyl-N-methyl-carbamate
|
卡巴拉汀脱甲基 |
923035-05-6 |
|
4,7-Methano-1H-isoindole-1,3(2H)-dione,2-[[(1R,2R)-2-[[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]-methyl]cyclohexyl]
methyl]hexahydro-,(3aR,4R,7S,7aS)
|
鲁拉西酮异构体 |
1318074-25-7 |
|
4-Desmethoxy-4-chloro Omeprazole Sulfide
|
2-[（RS）-[（4氯-3，5-二甲基-2-吡啶基）甲基] 硫基]-5-甲氧基-1H-苯骈咪唑 |
220757-74-4 |
|
5-(2-cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl)-7a-hydroxy-5,6,7,7a-tetrahydrothieno[3,2-c]pyridin-2(4H)-one
|
普拉格雷羟基杂质 |
947502-66-1 |
|
Omeprazole Sulfone N-Oxide
|
4-甲氧基-2-[[（5-甲氧基-1H-苯骈咪唑-2-基）磺酰基]甲基]-3，5-二甲基吡啶1-氧化物 |
158812-85-2 |
|
Pentanoyl chloride, 5-chloro-4-methyl-
|
5-氯，4-甲基戊酰氯 |
813452-05-0 |
|
Rosuvastatin EP IMpurity E Calcium Salt
|
瑞舒伐他汀钙EP杂质E（钙盐） |
|
|
5-chlorohexanoyl chloride
|
5-氯己酰氯 |
99585-01-0 |
|
(2R,3S/2S,3R)-2-(2,4-Difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol
|
(2R,3S/2S,3R)-2-(2,4-二氟苯基)-3-(5-氟嘧啶-4-基)-1-(1H-1,2,4-三唑- 1-基)-2-丁醇 |
182230-43-9 |
|
(S)-4-Desmethoxy-4-chloro Omeprazole
|
2-[（RS）-[（4氯-3，5-二甲基-2-吡啶基）甲基] 亚磺酰基]-5-甲氧基-1H-苯骈咪唑 |
863029-89-4 |
|
(S)-Sitagliptin Phosphate
|
S-西他列汀磷酸盐 |
823817-58-9 |
|
1-(4-Methoxyphenyl)-6-(4-(2-Methyl-6-oxopiperidin-1-yl)phenyl)-7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxaMide
|
阿哌沙班杂质2 |
2098457-92-0 |
|
2-[[2-2(2-Amino-4-thiazolyl)acetyl]amino]-4-thiazoleacetic Acid
|
2-(2-(2-(2-氨基噻唑-4-基)乙酰氨基)噻唑-4-基)乙酸 |
2036283-13-1 |
|
3S,5R isoMer, or (3S,5R)-7-[3-(phenylcarbaMoyl)-5-(4-fluorophenyl)-2-isopropyl-4-phenyl-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid calciuM salt(Atorvastatin EP IMpurity A)
|
阿托伐他汀钙杂质USP杂质B |
887196-25-0 |
|
2-[[(3,5-DiMethyl-2-pyridinyl)Methyl]thio]-6-Methoxy-1H-benziMidazole
|
2-[（RS）-[（3，5-二甲基-2-吡啶基）甲基]硫基]-5-甲氧基-1H-苯骈咪唑 |
704910-89-4 |
|
4,5,6,7-Tetrahydro-1-(4-methoxyphenyl)-6-[4-(5-methyl-2-oxo-1-piperidinyl)phenyl]-7-oxo-1H-pyrazolo[3,4-c]pyridine-3-carboxamide
|
阿哌沙班杂质1 |
1686149-74-5 |
